Skip to main content

TeleVox Acquires Odeza Patient Engagement Business from Ensemble Health Partners

Written by Customer Service on . Posted in Mergers And Acquisitions.

MOBILE, Ala., Sept. 05, 2023 (GLOBE NEWSWIRE) — TeleVox, the industry-leading provider of omnichannel digital patient engagement technology, has acquired the Odeza patient engagement business from Ensemble Health Partners (Ensemble), the leading revenue cycle management company for hospitals, health systems and physician practices.

Additionally, TeleVox and Ensemble will make TeleVox’s technology available to Ensemble’s customers, offering healthcare providers a comprehensive solution from patient acquisition to discharge and beyond.

“We welcome Odeza into the TeleVox family and the acquisition of their patient engagement business aligns with our 30 plus year commitment to providing tailored communication solutions that improve the patient experience and make TeleVox the industry leader,” said Vik Krishnan, President of TeleVox. “By making our patient engagement offerings available to the expansive customer base of Ensemble, we’ll help more healthcare providers deliver exceptional care to their patients.”

Today’s news continues a string of rapid growth and expansion for TeleVox. In April, TeleVox announced the launch of Iris™, an AI-enabled omnichannel conversational virtual assistant for healthcare providers. That announcement was followed a month later with the launch of its automated reputation management solution that empowers hospitals, health systems, and physician practices to take control of their online presence.

“This partnership strengthens each of our positions in the healthcare industry and delivers unmatched value to our customers,” said Judson Ivy, Founder, President and CEO of Ensemble Health Partners.

For more information about TeleVox solutions, please visit www.televox.com/request-a-demo.

About TeleVox
TeleVox is a leading provider of omnichannel digital patient engagement technology. Our solutions are used by more than 10,000 healthcare organizations—from hospitals and health systems to community health centers—to engage, educate, and empower patients throughout their care journey. Our patient engagement platform integrates with the electronic health record (EHR) to support automated, personalized, two-way interactions with patients. And our pharmaceutical team partners with life science companies to develop strategic disease state awareness, education, and vaccination reminders by reaching more patients through customized communication. All of these exchanges are possible via text, virtual assistant, interactive voice response (IVR), email, and postcards. For 30 years, TeleVox has helped preserve care continuity, reduce the operational burden on staff, and drive revenue while making the healthcare communication process easier for everyone. TeleVox is a part of West Technology Group, LLC controlled by affiliates of certain funds managed by Apollo Global Management, Inc. (NYSE: APO).

Learn more at www.televox.com.

About Ensemble Health Partners
Ensemble Health Partners is a full-service revenue cycle management company, delivering a holistic approach to financial health for more than 20 healthcare provider clients across the country. Ensemble provides a complete platform of services, technology, business intelligence and analytics to manage every aspect of revenue cycle operations so healthcare providers can focus on delivering exceptional patient care in their communities.

Contact
Donald Thompson
Head of Marketing
Donald.thompson@televox.com
(315) 720-3304

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.